Emcure Pharmaceuticals Gujarat plant clears USFDA inspection with zero observations Corporates · Oct 10, 2025
Emcure Pharmaceuticals shares jump 5% as Q4 profit rises 63% YoY to Rs 197.2 crore Stock Market · May 22, 2025
Emcure Pharmaceuticals receives EIR from USFDA with VAI classification for Kurkumbh API facility Corporates · Apr 18, 2025
Emcure Pharmaceuticals receives two observations for its Kurkumbh facility from US FDA after cGMP inspection Corporates · Feb 26, 2025
Emcure Pharmaceuticals Q3 FY25 Results: Revenue up 18% YoY to Rs 1963 crore, Net Profit up 30% YoY Corporates · Feb 6, 2025
Emcure Pharmaceuticals launches Emcutix Biopharmaceuticals to expand dermatology portfolio Corporates · Oct 28, 2024
Emcure Pharmaceuticals signs licensing agreement with Gilead for manufacture and supply of Lenacapavir Corporates · Oct 3, 2024